Drugs / RUSALATIDE
RUSALATIDE
also known as
Chrysalin · Rusalatida · RUSALATIDE ACETATE · Rusalatide acetate (3:2) · TP-508 ACETATE · TP508 · TRAP-508 · TRAP-508 ACETATE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00131482 | Nov 2004 → Mar 2007 | — | Capstone Therapeutics | Terminated | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RUSALATIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Known as | Chrysalin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00131482 ↗ |
| Known as | Rusalatida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Known as | RUSALATIDE ACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Known as | Rusalatide acetate (3:2) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Known as | TP-508 ACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Known as | TP508 | “The purpose of this study is to evaluate the safety of Chrysalin, also known as TP508, and to determine the effectiveness of four doses of Chrysalin for treating broken wrists...” NCT00131482 ↗ |
| Known as | TRAP-508 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Known as | TRAP-508 ACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111105 ↗ |
| Modality | Peptide | “Chrysalin, also known as TP508, is a synthetic peptide (protein)” NCT00131482 ↗ |
| Route | Other | “single percutaneous injection of Chrysalin 3 micrograms at the fracture site at the time of surgery” NCT00131482 ↗ |